Document:

Exhibit

EXHIBIT 10.19

Confidential information has been omitted in places marked “*****” and has been filed separately with the Securities and Exchange Commission.  Confidential treatment has been requested with respect to this omitted information.

Business Confidential Proprietary Information

TENEX Contract No. 08843672/110033-051
USEC Contract No. EC-SC01-11-UE-03127 
Amendment No. 007
AMENDMENT No. 007, signed as of October 19, 2015, to the Enriched Product Transitional Supply Contract, TENEX Contract No. 08843672/110033-051, USEC Contract No. EC-SC01-11-UE-03127, entered into on March 23, 2011 (the "Contract") by and between United States Enrichment Corporation ("USEC") and Joint Stock Company “TENEX”.  USEC and TENEX are referred to herein individually as a "Party" and collectively as the "Parties". Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Contract.
SECTION 1. Pursuant to Section 20.04 of the Contract, USEC and TENEX hereby agree as follows:
The following new Appendix 3 shall be inserted after Appendix E2:
		
	APPENDIX E3: 
	Supplemental Procedures for Natural Uranium Delivered Under Section 7.02(j) 

		
	E3-1
	Documentation Stating Quality and Quantity.  For each ***** Cylinder Delivered under Section 7.02(j) of the Contract, USEC shall issue a Certificate of Quality and Quantity (CQQ) in the English and Russian languages regarding the Natural Uranium it contains.  The English language will be deemed controlling in the event of a difference.

		
	E3-2
	Procedures for Sample Withdrawal and Testing of the Natural Uranium by TENEX.

		
	(a)
	Natural Uranium Physically Delivered to TENEX shall be shipped without samples under USEC's written certification in the CQQ of the Natural Uranium’s conformance to the American Society of Testing and Materials (“ASTM”) specification for commercial natural UF6, *****. Notwithstanding any other provision of the Contract, Natural Uranium meeting the requirements of the preceding sentence shall be deemed to be “Conforming Material” under the Contract. 

		
	(b)
	In order to verify the Natural Uranium is Conforming Material, TENEX may withdraw samples of Natural Uranium from any ***** Cylinder.  TENEX’s rights to reject Natural Uranium that is not Conforming Material is set out in Appendix E2, and the provisions of Paragraph E2-2 regarding Acceptance shall apply; provided, however, that, unless the delay in taking physical delivery is attributable to the fault of USEC, the ***** Acceptance period in Paragraph 

E2- shall be deemed to commence on the ***** of the transfer of title to the ***** Cylinder to TENEX pursuant to ***** if TENEX has not taken physical delivery of such ***** Cylinder by such anniversary date.  The fact that the seal on the valve and plug of a ***** Cylinder is broken for the purpose of withdrawing a sample to determine if Natural Uranium in Conforming Material shall not limit TENEX’s right to initiate a dispute concerning the Natural Uranium in that ***** Cylinder in accordance with Appendix E2.  If the seal is broken for any other purpose, then such right is waived by TENEX.
		
	E3-3
	Acceptance. 

After Acceptance of Natural Uranium Delivered hereunder as per Paragraph E2-2 and Paragraph E3-2(b) above, USEC shall thereafter have no responsibility for claims arising from non-conformance of the Natural Uranium contained in a ***** Cylinder.
		
	E3-4
	Replacement.

		
	(a)
	In connection with the terms governing replacement of defective Natural Uranium under Paragraph E2-3 of the Contract, at USEC's request, TENEX shall use its reasonable efforts to assist USEC in effecting the removal or disposition of the rejected Natural Uranium, including by accepting the Natural Uranium which is not Conforming Material in the ***** Cylinder upon payment by USEC of a reasonable surcharge or by transporting  the Natural Uranium to USEC, ***** (with USEC to pay the expense of shipment of the rejected Natural Uranium from the Russian enrichment plant to ***** and loading of the rejected Natural Uranium on *****).

		
	(b)
	In the case where USEC removes the rejected Natural Uranium and the ***** Cylinder containing it, USEC shall Deliver to TENEX the quantity of Natural Uranium in the rejected ***** Cylinder in accordance with Section 7.02(a) or Section 7.02(b) or Section 7.02(c) of the Contract.  

		
	(c)
	Pursuant to Paragraph E2-1 of the Contract, the Parties agree that a dispute about whether Natural Uranium Physically Delivered to TENEX under this Agreement is Conforming Material shall be resolved by submitting a mutually-agreed sample to a mutually agreed independent laboratory for analysis, which will act as the “umpire”. The umpire’s results shall be conclusive on all Parties if such results are within the range determined by TENEX's and USEC's results (as USEC’s results are reflected on the CQQ).  If the umpire’s results are outside the range determined by such results, TENEX and USEC shall accept the results of the Party that are nearest to the umpire’s results.  USEC shall pay the umpire’s costs if the umpire’s results establish that the Natural Uranium is not Conforming Material; otherwise, TENEX shall pay the umpire’s costs.  For this purpose, the “umpire’s costs” shall mean the umpire’s charges plus the additional costs, if any, of the packaging, handling and transporting the sample to and from the umpire.

		
	(d)
	USEC shall bear the expenses associated with removal and replacement of rejected Natural Uranium as provided in Paragraph E3-4(b) above.  TENEX shall invoice USEC for such expenses, and its invoice shall include supporting documentation for each expense.  Nothing herein shall relieve any Party of its obligation to use reasonable efforts to minimize the expenses to be reimbursed by another Party.

		
	E3-5
	Weight. 

The following shall apply to the determination of weights for Natural Uranium Physically Delivered to TENEX and the ***** Cylinder containing such Natural Uranium:
		
	(a)
	The Parties shall be bound by the cylinder tare weight listed in the CQQ provided by USEC.

		
	(b)
	The Parties shall also be bound by the gross weight listed on the CQQ; provided, however, that TENEX may dispute such gross weight if the gross weight determined by TENEX differs from the gross weight determination in the CQQ by more than the "Applicable Dispute Limit", which for this purpose shall mean a difference of ***** from the gross weight in the CQQ, and TENEX notifies USEC of such discrepancy prior to Acceptance of the Natural Uranium.  The Parties shall follow the check-weight procedures in Paragraph E3-6 below in resolving any dispute of the gross weight, and the resolution of such disputes in accordance with Paragraph E3-6 shall be final and binding on the Parties.  Notwithstanding the existence of a discrepancy in gross weight or a dispute concerning such discrepancy, USEC's gross weight determination shall be final and binding on the Parties if TENEX breaks the seal on, or evacuates any of the Natural Uranium from, the disputed ***** Cylinder prior to either resolution of the discrepancy or USEC's agreement to accept TENEX's gross weight determination.

		
	(c)
	For purposes of this Section, "net weight" shall mean the difference between the gross weight of a ***** Cylinder filled with Natural Uranium identified in the CQQ and the tare weight of such cylinder.

		
	(d)
	All ***** Cylinders have previously been weighed by or for USEC intends to use those weight results without reweighing.  If, however, USEC determines that it must reweigh a ***** Cylinder (or cause such cylinder to be reweighed) after execution of Amendment No. 007 to this Contract but before transfer of title to TENEX pursuant to the Cylinder Purchase Contract and, prior to USEC determining that it must reweigh the ***** Cylinder, TENEX has requested in a timely manner an opportunity to observe such reweighing, USEC shall promptly notify TENEX of the date(s) and place(s) for observance of such reweighing and TENEX shall be given an opportunity to observe, at TENEX's expense, the reweighing of the ***** Cylinder.  TENEX shall comply with the 

requirements for its observer to gain access to the place where the reweighing will occur.
		
	(e)
	Any re-weighing of filled ***** Cylinders is to be made with an accuracy of ***** of the gross weight of the filled cylinders, or ± *****, whichever is greater.

		
	(f)
	Any re-weighing of filled ***** Cylinders must be carried out on scales providing the accuracy of weighing not lower than mentioned in item (e) above.

		
	E3-6
	Check Weight Procedure.  

If, in accordance with Paragraph E3-5 of this Appendix, TENEX notifies USEC that the gross weight of a filled ***** Cylinder to which USEC has transferred title to TENEX pursuant to a Cylinder Purchase Contract differs by more than the Applicable Dispute Limit from the gross weight in the CQQ, then, if the discrepancy cannot be resolved by mutual agreement within ***** after USEC receives TENEX's notification (whichever receives the notification last), TENEX shall arrange for a separate weighing of the applicable cylinder to determine the gross weight of such filled cylinder (the “Check Weighing” or “Check Weighed”).  USEC shall have the right to witness the Check Weighing.  TENEX shall give USEC at least two weeks' Notice of the time and place for the Check Weighing.  The Check Weighing shall be conducted on calibrated scales and weighing machines properly certified for such purpose.  The Check Weighing procedure shall be as follows:
		
	(a)
	All Cylinders and/or weights shall be first removed from the scales, and the scales shall be zero-checked.

		
	(b)
	A mutually agreed standard weight shall then be placed on the scales in order to verify their accuracy.  If the indicated weight of the standard weight differs from its known weight by more than ***** of the standard weight the scales shall be re-calibrated.

		
	(c)
	The cylinder to be Check Weighed shall be examined to ensure that the valve protector and other removable items have been removed and then it shall be re-weighed.  The results of the re-weighing shall be defined as the "Check Weight."

		
	(d)
	If the Check Weight and the gross weight determination on the CQQ differ by an amount equal to or less than the Applicable Dispute Limit, USEC's gross weight determination shall be binding.

		
	(e)
	If the Check Weight and the original gross weight determination on the CQQ differ by more than the Applicable Dispute Limit, the Check Weight shall be binding.

		
	(f)
	Any costs incurred in connection with this Check Weighing procedure shall be borne by (i) TENEX if USEC's the original gross weight determination on the CQQ is binding, and (ii) USEC in all other cases.

		
	(g)
	If as a result of the Check Weighing it is determined that there is a shortfall in the quantity of Natural Uranium Physically Delivered in the ***** Cylinder as compared to the quantity identified in the CQQ, USEC shall *****

		
	(h)
	Neither TENEX nor any party acting on its behalf shall evacuate or break the seal on the valve and plug of a ***** Cylinder about which there is a dispute concerning gross weight until any discrepancy concerning weight is resolved under this Appendix E3.

7.    Maximum Permissible Levels of Radiation and Non-fixed Radioactive Contamination.
TENEX shall ensure that the transportation of ***** Cylinders with Natural Uranium shall be effected in accordance with IAEA Safety Standards Series No.TS-R-1, Regulations for the Safe Transport of Radioactive Material, 2009 Edition.
8.    Marking.
		
	(a)
	Pursuant to the Cylinder Purchase Contract, each ***** Cylinder shall have a permanent marking (nameplate) at the time title to the ***** Cylinder transfers to TENEX.   Thereafter, any changes in labelling shall not be USEC’s responsibility.

		
	(b)
	The permanent marking described in Paragraph E3-8(a) shall be made on a metal plate fixed to ***** Cylinder. It shall be non-exchangeable and non-erasable. The permanent marking must contain the data stipulated in ANSI N 14.1.

9.    Conversion Coefficient. 
The weight of uranium in Natural Uranium indicated in the shipping documentation for a ***** Cylinder shall be determined as the weight of uranium hexafluoride multiplied by a coefficient (Factor F) in the range of *****.  Factor F shall be indicated in the CQQ. 
10.    Certificate of Quality and Quantity.  
All measured and weighing values shall be stated in the CQQ, in kilograms rounded to the nearest integer number of kilograms, taking into account that the first decimal equal or less than 4 leaves the integer unchanged, the first decimal greater than 5 increases the integer by 1, and if the first decimal is equal to 5, the integer is increased by one if the integer is odd while if the integer is even the integer is unchanged.

11.    Modification of Forms.
If Physical Delivery is made from a location other than the *****, the references to the ***** shall be adjusted accordingly.
SECTION 2. Except as amended hereby, the Contract shall remain unchanged and in full force and effect.
SECTION 3. This Amendment No. 007 may be executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken together, shall constitute one and the same instrument.
IN WITNESS WHEREOF, the Parties hereto have executed this Amendment No. 007 as of the date first written above.

	
			
	UNITED STATES ENRICHMENT CORPORATION
	 
	JOINT STOCK COMPANY "TENEX"

	By:  /s/ Stephen S. Greene
	 
	By:  /s/ Oleg Kozin

	Name:  Stephen S. Greene
	 
	Name:  Oleg Kozin

	Position:  SVP, CFO & Treasurer
	 
	Position:  Acting First Deputy General Director for CommerceExhibit

EXHIBIT 10.20

Confidential information has been omitted in places marked “*****” and has been filed separately with the Securities and Exchange Commission.  Confidential treatment has been requested with respect to this omitted information.

Business Proprietary Confidential Information

TENEX Contract No. 08843672/110033-051
USEC Contract No. EC-SC01-11-UE-03127 
Amendment No. 008
AMENDMENT No. 008, signed as of December 22, 2015, to the Enriched Product Transitional Supply Contract, TENEX Contract No. 08843672/110033-051, USEC Contract No. EC-SC01-11-UE-03127, entered into on March 23, 2011 (the "CONTRACT") by and between United States Enrichment Corporation ("USEC") and Joint Stock Company "TENEX" ("TENEX").  USEC and TENEX are referred to herein individually as a "Party" and collectively as the "Parties". Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the CONTRACT.
SECTION 1. Pursuant to Section 20.04 of the CONTRACT, USEC and TENEX hereby agree as follows:
		
	1.
	Section 1.18 shall be replaced with the following:

 “1.18    Deliver, Delivery or Delivered 
(a)     in reference to Natural Uranium:
		
	(i)
	a Book Transfer (as defined in Section 1.07) pursuant to Section 7.02(a), 

		
	(ii)
	a Physical Delivery (as defined in the applicable provision of Section 1.44) pursuant to Section 7.02(b) or  (c),  or

		
	(iii)
	the transfer of title pursuant to Section 7.02(h)(iii) or Section 7.02(j)(ii), 

as indicated by the context in which these terms are used, or
		
	(b) 
	in reference to EUP or SWU contained in EUP, Physical Delivery as defined in Section 1.44(a), or 

		
	(c)
	a transfer of title, when so agreed by the Parties, or

		
	(d)
	in reference to other items, such as Cylinders, Physical Delivery of such items (as defined in Section 1.44(b) or (e), as applicable).” 

		
	2.
	The following shall replace all of Section 3.01 and Sections 3.02(a), (b) and (c):

		
	“3.01
	TENEX shall supply to USEC, and USEC shall procure from TENEX, EUP containing the following fixed quantities of SWU (“Firm Commitment SWU”) shown in column 2 of Table 1A below, subject to the permitted transfer of certain quantities to Delivery Years 2023-26 under Section 3.02 and the increase in those transferred quantities under Section 3.02(c) (defined therein as “Compensatory Purchases”).

Table 1A: Firm and Optional SWU Purchase Quantities 2016-22
	
			
	Calendar year of Delivery
(column 1)
	Firm Commitment SWU
(column 2)
	

Mutual Option SWU
(column 3)

	2016
	2,250,000
	3,000,000

	2017
	2,250,000
	3,000,000

	2018
	2,250,000
	3,000,000

	2019
	2,250,000
	3,000,000

	2020
	2,542,000
	3,000,000

	2021
	2,542,000
	3,000,000

	2022
	2,542,000
	3,000,000

The Parties hereby confirm that their purchase, sale and Delivery obligations under this CONTRACT for Delivery Years prior to 2016 have been satisfied, with the exception of (a) any obligations of USEC to pay invoices for SWU in EUP Delivered in Delivery Year 2015 (the “2015 EUP”) that have yet to be fully paid as of the first day by which both Parties executed Amendment No. 008 to the CONTRACT (the “Amendment 008 Execution Date”); (b) any obligations of USEC to supply Related Natural Uranium for the 2015 EUP that, as of the Amendment 008 Execution Date, has not already been Delivered under Section 7.02; and (c) any obligations of either Party with respect to the quantity or quality of the 2015 EUP or other Material Delivered in 2015 that has not yet been Accepted as of the Amendment 008 Execution Date.
		
	3.02 
	The portions of Firm Commitment SWU in Table 1A, mentioned in the Row 2 of Table 1B (the “Non-Transferable SWU”), shall be purchased by USEC and Delivered in the respective Delivery Years indicated in Row 1 of Table 1B, and the portions of Firm Commitment SWU in Table 1A mentioned, in Row 3 of Table 1B (the “Transferable SWU”), shall be purchased by USEC and Delivered in the period 2016-2026, subject to the terms below.

Table 1B: Non-Transferable and Transferable Firm Commitment SWU Purchase Quantities 2016-22
	
									
	Row 1
	Delivery Year:
	2016
	2017
	2018
	2019
	2020
	2021
	2022

	Row 2
	Non-Transferable SWU
	*****
	*****
	*****
	*****
	*****
	*****
	*****

	Row 3
	Transferable SWU
	*****
	*****
	*****
	*****
	*****
	*****
	*****

*****
		
	(a)
	*****

		
	(b)
	To the extent not all of the Transferable SWU quantities in Row 3 of Table 1B are ordered to be Delivered before Delivery Year 2023 (such unordered portion of the Transferable SWU quantities being defined as the “Remaining SWU”), USEC shall order the Remaining SWU quantities plus Compensatory Purchases under Section 3.02(c) (together, the “Post-2022 Quantities”) for Delivery in EUP in 2023 through 2026 according to the following schedule, subject to Section 3.02(d):

		
	(i)
	*****

		
	(ii)
	*****

		
	(iii)
	*****

		
	(iv)
	*****

		
	(c)
	Subject to Section 3.02(d), USEC’s SWU purchase obligations for Delivery Years 2023-26 shall be increased by the following amounts of SWU (“Compensatory Purchases”) to compensate for (i) the reduction in purchase volumes in 2016-22 as compared to the Firm Commitment SWU in Table 1A and their deferral to later years (the “Deferral Compensation”) and (ii) *****, as follows:

		
	(x)
	*****

		
	(y)
	*****

		
	(1)
	*****

		
	(2)
	*****

		
	(z)
	*****

		
	(d)
	Notwithstanding the foregoing, USEC shall not be obligated to purchase more than 2.25 million SWU in any Delivery Year after 2022 under this Section 3.02.  Instead, USEC shall have the right to defer the purchase of the excess over 2.25 million SWU until the first Delivery Year in which such excess can be purchased without resulting in an obligation for USEC to purchase more than 2.25 million SWU.  There shall be no additional compensation in SWU owed for the deferral of such excess.” 

		
	3.
	The following new Sections 3.06, 3.07 and 3.08 shall be inserted at the end of Article 3:

		
	“3.06
	*****

		
	3.07
	*****

		
	3.08
	*****”

		
	4.
	The opening phrase of Section 4.03 shall be replaced with the following: 

 
		
	“4.03
	USEC shall place binding Orders with TENEX for Deliveries during the Delivery Year of EUP containing, in the aggregate, a nominal amount of SWU sufficient to satisfy USEC’s purchase obligations pursuant to Article 3 for such Delivery Year, subject to all of the following:”

		
	5.
	The last sentence of Section 4.03(f) shall be deleted.  

		
	6.
	In Section 4.05, the phrase “*****” shall be replaced with “*****”.  In addition, the following two sentences shall be inserted at the end of Section 4.05:

*****
		
	7.
	The following phrase shall be deleted from Section 4.06:  “(assuming, for this purpose, that USEC would exercise the option in Section 3.02 to reduce its purchase obligation by 5% for the SWU Component of all EUP ordered or to be ordered for such Delivery Year)”.

		
	8.
	In Section 4.06(a), the following shall be inserted after the phrase “from August 1st of the Delivery Year”:

*****
		
	9.
	Section 4.06(f) shall be replaced with the following:

		
	“(f)
	If for any reason USEC has not placed all required Orders (that comply with the CONTRACT requirements) ***** (the SWU in (A) or (B), as applicable, being referred to as USEC’s “Minimum Firm Purchase Obligation” for that Delivery Year), TENEX shall have the right, starting from ***** (the “Applicable Purchase 

Deadline”), at its sole discretion and with prior Notice to USEC, to exercise remedies *****
		
	(i)
	TENEX may invoke the remedy in Section 4.06(c) at any time after the Applicable Purchase Deadline notwithstanding any contrary term in Section 4.06(c), without the need for TENEX either to seek to sell such Purchase Quantity Shortfall to one or more third parties prior to invoking such remedy or to wait until ***** to invoke such remedy.  Further, in the case of a Purchase Quantity Shortfall for which TENEX elects the remedy in this Section 4.06(f)(i), the liquidated damages under Section 4.06(a) applicable to such Purchase Quantity Shortfall shall be payable ***** after receipt by USEC of the invoice from TENEX for the full period in Section 4.06(a) from *****, without regard to whether TENEX has sold the applicable Purchase Quantity Shortfall.

		
	(ii)
	If the Purchase Quantity Shortfall is greater than *****, TENEX may elect the remedy in (A) - (D) below with respect to all or part of the Purchase Quantity Shortfall, at TENEX’s election (the “Immediate Payment Remedy”).  This remedy shall apply in lieu of the remedies under Section 4.06(a) and Section 4.06(b), as modified by Section 4.06(f)(i) (collectively, the “Accelerated Cover Damages Remedy”).  The Accelerated Cover Damages Remedy shall still apply to any portion of the Purchase Quantity Shortfall for which TENEX does not elect the Immediate Payment Remedy.

		
	(A)
	Under the Immediate Payment Remedy, TENEX may invoice USEC the SWU Price applicable to the Shortfall Year under Section 6.01(a) multiplied by the SWU in the portion of the Purchase Quantity Shortfall for which TENEX elects the Immediate Payment Remedy. 

		
	(B)
	This invoice shall be paid by USEC *****

		
	(C)
	After paying the invoice under Section 4.06(f)(ii)(B), USEC shall place one or more Orders for Delivery in the Delivery Year immediately after the Shortfall Year (the “Makeup Year”) of Related EUP containing the portion of the Purchase Quantity Shortfall for which TENEX elected the Immediate Payment Remedy (the “Prepaid SWU”). For the avoidance of doubt, in case (other than as a result of an impediment under Section 13.03), USEC does not place one or more Orders for Delivery in the Makeup Year of the whole amount of the Prepaid SWU, USEC shall have no right to place Orders for Delivery of any Prepaid SWU in any year after the Makeup Year.

		
	(D)
	For each Delivery in the Makeup Year of the Prepaid SWU USEC shall ***** after receipt of the TENEX invoice by USEC following each such Delivery, pay to TENEX the positive difference between the SWU Price in the Shortfall Year and the SWU Price in the Makeup Year, if there is such a difference, multiplied by the portion of the Prepaid SWU 

contained in the respective Delivery.  The first SWU ordered for Delivery in the Makeup Year shall be considered to be the Prepaid SWU.  
		
	(E)
	*****

		
	(F)
	With respect to USEC’s Orders for Delivery in the Makeup Year, Related EUP containing the Prepaid SWU, USEC shall Deliver the Feed Material for such Related EUP in accordance with the terms of this CONTRACT. 

		
	(iii)
	*****

		
	(iv)
	For the avoidance of doubt, all remedies based upon a damages claim under Section 4.06(c), including those in Section 4.06(f)(i), are subject to Section 4.06(d) but Section 4.06(d) does not limit the remedy in Section 4.06(f)(ii).  Further, the remedy in Section 4.06(a) shall not apply to any portion of the Purchase Quantity Shortfall for which TENEX elected the Immediate Payment Remedy.

		
	(v)
	*****

		
	(vi)
	*****

		
	(vii)
	*****

		
	(A)
	*****

		
	(B)
	*****

		
	(1)
	*****

		
	(2)
	*****

		
	(3)
	*****

		
	(4)
	*****

		
	10.
	The last two paragraphs of Section 4.06 shall be replaced with the following:

“(g)    TENEX shall inform USEC of the steps initiated by TENEX as far as these steps concern USEC, and shall use its reasonable efforts to minimize the amounts owed by USEC pursuant to the foregoing provisions of this Section 4.06.  To the extent permitted by applicable law and subject to Section 18.09, the foregoing provisions of this Section 4.06 shall be TENEX’s exclusive remedy for a Purchase Quantity Shortfall or for USEC’s failure to submit Orders with respect to a Delivery Year, but is without prejudice to any rights or remedies that TENEX may have under this CONTRACT or applicable law with respect to future Delivery Years if USEC does not provide adequate, in TENEX’s reasonable judgment, assurances that the failure to submit sufficient Orders will not recur in such future Delivery Years.

For the avoidance of doubt, if USEC fails to provide such assurances, TENEX may pursue its rights and remedies under applicable law and this CONTRACT with respect to an anticipated breach of USEC’s obligation to place Orders in future Delivery Years under the Dispute resolution procedure in Article 18 and any resulting damage award shall be subject to the limitations in Article 11.
With respect to any Delivery Year in which USEC did not meet its Minimum Firm Purchase Obligation but did meet in a timely manner 100% of its financial obligations under Section 4.06(f) with respect to the Purchase Quantity Shortfall, USEC’s assurances shall be presumed to be adequate absent credible evidence of fraud or intentional misconduct.”
		
	11.
	*****  Further, Section 6.01(b) and (c), shall be hereby renumbered Section 6.01(c) and (d), respectively, and the following new Section 6.01(b) is hereby inserted prior to the renumbered Section 6.01(c):

		
	“(b)
	*****”

		
	12.
	In the renumbered Section 6.01(c) (formerly Section 6.01(b)), the reference to Section 6.01(b)(ii) is hereby replaced with “Section 6.01(c)(ii)” and the reference to Section 6.01(b)(i) is hereby replaced with “Section 6.01(c)(i)”.

		
	13.
	The following phrase shall be deleted from Section 11.02:

“(assuming, in the case of a prospective failure to Deliver EUP in future Delivery Years, that USEC would have exercised its option under Section 3.02 to increase by 5% the quantity of SWU to be purchased for such Delivery Years.)” 
		
	14.
	*****

		
	15.
	*****

		
	16.
	Appendix J of the CONTRACT is hereby replaced with the revised Appendix J in Exhibit 1 hereto.  Appendix P in Exhibit 2 hereto is hereby inserted as a new appendix to the CONTRACT.

SECTION 2.    This Amendment No. 008 shall take effect upon signature by the Parties and approval by the State Atomic Energy Corporation “Rosatom” (“ROSATOM”).  TENEX shall promptly notify USEC in writing upon receipt of the approval of this Amendment No. 008 by ROSATOM.  Except as amended hereby, the CONTRACT, as in effect on the date first written above, shall remain unchanged and in full force and effect.
SECTION 3.    This Amendment No. 008 may be executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken together, shall constitute one and the same instrument.
IN WITNESS WHEREOF, the Parties hereto have executed this Amendment No. 008 as of the date first written above.

	
			
	UNITED STATES ENRICHMENT CORPORATION
	 
	JOINT STOCK COMPANY "TENEX"

	By:  /s/ Daniel B. Poneman
	 
	By:  /s/ Zalimskaya L.

	Name:  Daniel B. Poneman
	 
	Name:  Zalimskaya L.

	Position:  President and CEO
	 
	Position:  General Director 

Business Proprietary Confidential Information

Exhibit 1
APPENDIX J:    *****

Business Proprietary Confidential Information

Exhibit 2
APPENDIX P:    *****

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00256-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00256-of-00352.parquet"}]]